(Total Views: 564)
Posted On: 12/03/2024 8:51:31 PM
Post# of 148870
Pestell came back because of what Dr. J ( & GSK ?) was working on.
May 13th, 2022:
Dr. Jay Lalezari to Serve as Outside Scientific Advisor
May 19th, 2022 Pestell legsl settlement excerpt:
4.Press Release.
Promptly after execution of this Agreement, the Company shall issue a press release, in the form attached hereto as Exhibit D, announcing: (i) the settlement of the Litigation;
(ii) that the Company regrets (a) Dr. Pestell’s prior departure from the Company and (b) the public statements made by the Company’s prior CEO about Dr. Pestell after such departure;
and (iii) that Dr. Pestell and the Company are exploring ways in which Dr. Pestell can reengage with the Company to help realize Leronlimab’s potential in oncology.
___
May 23, 2022:
CytoDyn Announces Resolution of Legal Dispute with Former Chief Medical Officer
___
Later in 2022 Cytodyn hires x-GlaxoSmithKline biostatistics guy, of 30 yrs.
@ minimum, all adds up to planning / expecting, great success in oncology.
May 13th, 2022:
Dr. Jay Lalezari to Serve as Outside Scientific Advisor
May 19th, 2022 Pestell legsl settlement excerpt:
4.Press Release.
Promptly after execution of this Agreement, the Company shall issue a press release, in the form attached hereto as Exhibit D, announcing: (i) the settlement of the Litigation;
(ii) that the Company regrets (a) Dr. Pestell’s prior departure from the Company and (b) the public statements made by the Company’s prior CEO about Dr. Pestell after such departure;
and (iii) that Dr. Pestell and the Company are exploring ways in which Dr. Pestell can reengage with the Company to help realize Leronlimab’s potential in oncology.
___
May 23, 2022:
CytoDyn Announces Resolution of Legal Dispute with Former Chief Medical Officer
___
Later in 2022 Cytodyn hires x-GlaxoSmithKline biostatistics guy, of 30 yrs.
@ minimum, all adds up to planning / expecting, great success in oncology.
(6)
(0)Scroll down for more posts ▼
